Director Donald Zurbay receives 6,871 Dentsply Sirona (XRAY) RSUs

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Donald Zurbay reported a stock-based award from the company. On 01/26/2026, he was granted 6,871 shares of common stock at a price of $0, reflecting an equity grant rather than a purchase.

According to the footnote, the award consists entirely of Restricted Stock Units that vest in full one year from the grant date, after which the restrictions lapse. Following this grant, Zurbay beneficially owns 6,871 shares directly, aligning his interests more closely with shareholders through additional equity compensation.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zurbay Donald

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,871	$0.00	--

Holdings After Transaction: Common Stock — 6,871 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zurbay Donald

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/26/2026		A		6,871(1)	A	$0	6,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Donald J. Zurbay	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Donald Zurbay?

Donald Zurbay, a director of DENTSPLY SIRONA, reported receiving 6,871 shares of common stock on 01/26/2026. The shares were granted at $0 per share as an equity award, rather than acquired through an open-market purchase.

How many DENTSPLY SIRONA (XRAY) shares did the director beneficially own after the grant?

After the reported transaction, Donald Zurbay beneficially owned 6,871 shares of DENTSPLY SIRONA common stock. This figure reflects the full amount from the 01/26/2026 equity grant reported in the filing as directly held.

What type of award did DENTSPLY SIRONA (XRAY) grant to director Donald Zurbay?

The award to Donald Zurbay consists entirely of Restricted Stock Units (RSUs). These RSUs convert into shares of common stock once vesting conditions are met, providing equity-based compensation rather than an immediate cash payment.

When do Donald Zurbay’s DENTSPLY SIRONA (XRAY) RSUs vest?

The Restricted Stock Units granted to Donald Zurbay vest in full one year from the date of grant. At that time, the restrictions lapse, and the RSUs are scheduled to convert into DENTSPLY SIRONA common shares.

Was there any cash paid for the DENTSPLY SIRONA (XRAY) shares granted to the director?

No cash was paid for these shares. The Form 4 shows a transaction price of $0 per share, indicating the 6,871 shares were issued as an equity grant rather than purchased for cash consideration.

Is Donald Zurbay a director or officer of DENTSPLY SIRONA (XRAY) in this filing?

In this filing, Donald Zurbay is identified as a director of DENTSPLY SIRONA Inc. He is not listed as an officer or 10% owner, and the Form 4 is filed for a single reporting person.